Alnylam Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Alnylam Pharmaceuticals Inc
CIK #0001178670
EDGAR Form CIK 2011 - 2025
10-K [0001178670]
10-Q [0001178670]
3 [0001178670]
4 [0001178670]
5 [0001178670]
8-K [0001178670]
SC 13G [0001178670]
Form 13D/13G Filer Form 13D/13G Subject Filed
Capital Research Global Investors Alnylam Pharmaceuticals Inc [2025-02-13]
Capital World Investors Alnylam Pharmaceuticals Inc [2022-09-09]
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2022-02-14]
Baillie Gifford & Co Alnylam Pharmaceuticals Inc [2020-02-03]
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2017-12-11]
BlackRock Inc Alnylam Pharmaceuticals Inc [2017-01-30]
Dodge & Cox Alnylam Pharmaceuticals Inc [2016-12-09]
Vanguard Group Inc Alnylam Pharmaceuticals Inc [2016-02-10]
BlackRock Inc Alnylam Pharmaceuticals Inc [2016-01-28]
Sanofi Alnylam Pharmaceuticals Inc [2014-03-05]
View All
Form 3/4/5 Subject 2011 - 2025
Alnylam Pharmaceuticals Inc
Bonney Michael W
Greenstreet Yvonne
Poulton Jeffrey V.
Fitzgerald Kevin Joseph
Tanguler Tolga
Garg Pushkal
Ausiello Dennis A
Sigal Charles Elliott
Bertozzi Carolyn R
View All
Terms | Privacy | Guide
tony@aum13f.com